Update your location to show providers, locations, and services closest to you.
Cancer Specialist (Oncologist), Hematology and Oncology Specialist
Brian Ramnaraign, MD is an assistant professor of medicine in the division of hematology and oncology at the University of Florida College of Medicine.
Dr. Ramnaraign attended the University of Toronto for his undergraduate studies where he was awarded an Honors Bachelors of Science degree with a specialization in molecular genetics and microbiology. This was followed by attending St. George’s University for his medical training where he was awarded the degree of Doctor of Medicine and graduated cum laude.
His internal medicine residency was completed at SUNY Downstate in Brooklyn, NY where Dr. Ramnaraign had the opportunity to participate in rotations at Memorial Sloan Kettering in Manhattan. After residency he obtained a fellowship in geriatrics at the University of Pennsylvania in Philadelphia, PA.
Dr. Ramnaraign completed his hematology and oncology fellowship here at the University of Florida and upon completion stayed on as faculty. His wife is also here at the University of Florida and is training to be a pediatric oncologist.
His expertise and research interests are in the fields of genitourinary cancers, gastrointestinal cancers and neuroendocrine cancers. He is interested in the role of targeted therapies and immunotherapies in providing personalized treatments to individuals with advanced cancers.
This phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher gene risk) of treatment to better match therapies to an individual patient's cancer aggressiveness.…
This phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroendocrine tumors. Chemotherapy drugs, such as capecitabine and temozolomide, work in…
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
Vern Gransden entered his treatment room at 7:40 a.m., bleary-eyed and crabby. He shared a look with his doctors. “Go get a cup of coffee, Vern,” one of them…
Pancreatic neuroendocrine tumors accompany a rare form of pancreatic cancer that account for only 1-2% of all pancreatic tumors. I usually tell my patients…
